NR0B2 and breast cancer: Higher NR0B2 expression is associated with fewer disease relapse and progression in liver cancer patients and is also associated with a favorite overall survival prognosis in human breast cancers, lung adenocarcinomas, liposarcomas, and eye uveal melanomas.